Investing.com - Oppenheimer在美国医疗保险和医疗补助服务中心 (CMS)对三尖瓣经导管边缘对边缘修复术 (T-TEER)作出最终决定后，重申了对雅培实验室 ( Abbott Laboratories ) (NYSE: ABT )的"优于大盘"评级和140美元的目标价。

A Los Alamos home was featured in one of the biggest summer blockbusters. Now, a group is trying to open it up for the public ...

John Stoltzfus, Oppenheimer chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss how market could ...

Avatar director James Cameron revealed that he wasn't a fan of Christopher Nolan's Oppenheimer because Nolan didn't show the ...

近年来，理论化学动力学领域的核心任务之一是发展可靠的轨迹动力学方法，以在分子模拟中考虑原子核量子效应。原子核量子效应在许多复杂的化学和生物体系中扮演着至关重要的角色。与此同时，当体系的不同电子态势能面非常接近甚至出现简并时，电子态间的耦合不可忽略，导 ...

While the song’s backstory might be staged on its cover - a recreation of the moment Harry Houdini was supposedly passed a ...

“Yeah…it’s interesting what he stayed away from,” Cameron, 70, told Deadline of Nolan, 54, when asked if he was surprised Oppenheimer won seven Oscars and grossed nearly $1 billion. “Look, I love the ...

Filmmaker James Cameron calls "Oppenheimer" a "moral cop-out" for avoiding bombing aftermath scenes, as he develops his own ...

Investing.com - Oppenheimer周一将Capricor Therapeutics (NASDAQ: CAPR )的目标价从43.00美元下调至22.00美元，同时维持对该股的"优于大市"评级。此次调整发生之际，CAPR股价在过去一周下跌超过33%，尽管 InvestingPro 数据显示该股在过去一年仍上涨了76%。

This Best Picture Oscar winner sailed past $2 billion at the global box office, and it’s not Oppenheimer or Forrest Gump!

Cameron isn't the first critic to raise that particular issue with Oppenheimer; Spike Lee, to name one critic, has said, "If ...

Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.